A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder.

@article{Pavuluri2006AOO,
  title={A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder.},
  author={Mani N. Pavuluri and David B. Henry and Julie A Carbray and Gwen A Sampson and Michael W. Naylor and Philip G. Janicak},
  journal={Journal of child and adolescent psychopharmacology},
  year={2006},
  volume={16 3},
  pages={336-50}
}
OBJECTIVE The aim of this study was to assess the safety and efficacy of risperidone augmentation of lithium in preschool-onset bipolar disorder (BD) among youth who insufficiently respond to lithium monotherapy. METHOD Thirty-eight subjects between the ages of 4 and 17 years (mean age = 11.37 +/- 3.8 years) with onset of BD in preschool years (manic or mixed episode) entered this 12-month trial. All subjects received lithium monotherapy. Patients who failed to adequately respond to lithium… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Similar Papers

Loading similar papers…